Diligence memo · auto-generated · as of July 2, 2026
Ramona Optics, Inc.
Ramona Optics, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Ramona Optics, Inc. operates in Biotechnology, based in DURHAM.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ramona Optics, Inc. has raised $28M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $26M on 2026-02-25.
Most recent recorded round closed around 2026-02-25.
Valuation (modeled)modeled
Provath models Ramona Optics, Inc. at approximately $91M (range $52M–$119M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.18× the median modeled value of Series B Biotechnology companies in 2025–2027 (94 peers) — value vs value, same stage and era. Within the normal band (118% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 31 months.
Last raise 4 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 65.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 73% of Biotechnology peers (4293 compared).
Modeled value ranks above 57% of those peers.
Closest niche peers: MarvelBiome, Inc., Iantrek, Inc., Dualitas Therapeutics, Inc., Antares Therapeutics, Inc., OrthoBio Therapeutics, Inc..
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.